Pharmaceutical industry
The US Food and Drug Administration has granted emergency use authorization to Pfizer and BioNTech's COVID-19 vaccine, BNT162b2, for individuals 16 years of age or older, paving the way for a mass vaccination campaign in the US. This development is a significant milestone in the fight against the
COVID-19
As the COVID-19 vaccine becomes more widely available, employers are left to ponder whether they can require their employees to take the vaccine as a condition of employment. The U.S. Food and Drug Administration (FDA) advisory committee has recommended approval of the Pfizer COVID-19 vaccine under an Emergency Use
COVID-19
The United States marked a significant milestone in its battle against the Covid-19 pandemic on Friday, granting approval for the nation's first vaccine. This move, facilitated by the FDA's emergency use authorization, paves the way for widespread immunization, starting with health workers and nursing home residents.
Pharmaceutical industry
Stocks wavered on Thursday as investors weighed the impact of bogged-down stimulus talks and the latest jobless claims report, which showed a significant surge in Americans seeking unemployment benefits. The Dow Jones Industrial Average declined marginally, while the S&P 500 and Nasdaq exhibited contrasting trends. TheStreet's
Pharmaceutical industry
The ongoing COVID-19 pandemic has accelerated the development of new therapies and vaccines to combat the disease. Scientists are investigating various treatments, including drugs used to treat malaria and autoimmune diseases, antiviral drugs for other viruses, and antibodies from individuals who have recovered from COVID-19. However, the pandemic has also
COVID-19
The US could initiate COVID-19 vaccinations as early as this Friday, according to James Hildreth, a Food and Drug Administration (FDA) vaccines advisor. This development comes after a meeting of experts on Thursday, where Pfizer's vaccine is set to be assessed for emergency use authorization. Dr. Moncef Slaoui,
COVID-19 vaccines
FDA Commissioner Stephen Hahn met with White House chief of staff Mark Meadows for the second day in a row on Wednesday, amid growing frustration from President Trump and White House officials over the delayed approval of the Pfizer coronavirus vaccine in the US. The meeting comes as the UK
COVID-19 vaccines
Moncef Slaoui, the chief science advisor to President Donald Trump's Operation Warp Speed, has emphasized the importance of taking the COVID-19 vaccine, citing a "social responsibility" to do so. In a recent interview with The Washington Post, Slaoui urged Americans to think critically about the vaccine
Cybernet Data Systems Inc.
Trxade Group, Inc. has withdrawn its Emergency Use Authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for its partner's manufacture of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit. The decision follows FDA guidance, which states that only one EUA application is allowed per
Cybernet Data Systems Inc.
Amicus Therapeutics is a patient-dedicated biotechnology company focused on discovering, developing, and delivering novel medicines for rare diseases. The company's cornerstone product, Galafold(R) (also referred to as "migalastat"), has achieved widespread global approval as the first and only approved oral precision medicine for people living
Pharmaceutical industry
Sanofi, a global healthcare leader, has made a significant breakthrough in the treatment of type 2 diabetes with its investigational fixed-ratio combination of insulin glargine 100 Units/mL and lixisenatide. The company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for the treatment
Pharmaceutical industry
Sanofi, a French pharmaceutical company, has submitted an application to the US Food and Drug Administration (FDA) for the approval of LixiLan, a single daily insulin injection that can treat people with type 2 diabetes. The company has also requested a six-month review of the application, which is a significant
